L

Lumobiotics GmbH

2 employees

Lumobiotics develops light-controllable peptide drugs as safe cytolytic agents for treatment of solid cancers.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Peptidomimetics

Biotechnology

Infectious diseases

Therapeutics

Photoswitchable drugs

Peptides

Startup

Health Care

Oncology

Drug development

Pharmaceuticals

Date founded

2017

FAQ